Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Merck strengthens immunotherapy expertise with $773m buy
Americas
US-based Merck & Co has announced plans to buy Tilos Therapeutics, its latest acquisition in the immunotherapy space.   11 June 2019
USITC issues judgment in cholesterol testing strips dispute
Biotechnology
The US International Trade Commission has issued a judgment after a surgical appliances company, Polymer Technology Systems (PTS), filed a complaint against a China-based competitor.   10 June 2019
Eli Lilly petitions SCOTUS in $20m Cialis suit
Americas
Eli Lilly has asked the US Supreme Court to reconsider a lower court’s ruling which ordered the drugmaker to pay Germany-based Erfindergemeinschaft UroPep $20 million for patent infringement.   10 June 2019
Big Pharma
A group of more than 100 medical, scientific, patient advocacy and women’s health organisations have opposed a recent proposal to amend section 101 of the US Patent Act.   6 June 2019
Europe
The EU’s General Court has upheld the European Union Intellectual Property Office’s finding that a trademark for dietary supplements was descriptive of the relevant services to an Italian speaking public.   6 June 2019
Americas
San Francisco-based biotech company Atomwise could be set to receive up to $1 million per target in milestone payments following a partnership agreement with Eli Lilly.   6 June 2019
Big Pharma
A German court has rejected a bid from French pharmaceutical company Sanofi to have a patent infringement case dismissed.   5 June 2019
Genetics
Danish research company Bioneer has secured a non-exclusive licence to CRISPR/Cas9 technology owned by French geneticist Emmanuelle Charpentier.   4 June 2019
Big Pharma
A Japanese court has dismissed a patent infringement lawsuit brought by Roche subsidiary Genentech against Sandoz, a division of Novartis.   4 June 2019
Big Pharma
The US Food and Drug Administration has sent a warning letter to a stem cell company for marketing a number of unapproved treatments for a variety of life-threatening conditions.   4 June 2019